FDA Investigator Marlo Ianm Alintanahin
Marlo Ianm Alintanahin has conducted inspections on 62 sites in 7 countries as of 27 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
62
Last Inspection Date:
27 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Japan,
Germany,
Taiwan,
Ireland,
China,
Korea (Republic of)
FDA Investigators that have inspected at least one site in common with Marlo Ianm Alintanahin:
Akbar J Zaidi,
Alexandria L Capuano,
Alla Dubrovsky,
Anderson,
Andrew A Leboeuf,
Angelica G Aziz,
Binh T Nguyen,
Brenda G Stewart Munoz,
Brian P Putz,
Casey L Hamblin,
Cathleen A Carr Sharpe,
Cathy L Condon,
Charles L Larson,
Cheryl D Mccall,
Christine I Shaw,
Christopher W Buser,
Creighton T Tuzon,
Cynthia A Harris, MD, RN,
Cynthia J Tsui,
Cynthia L Gorveatt,
Dannie E Rowland,
David A Gonzalez,
Dejon N Harris,
Dennis G Kawabata,
Dennis R Hock,
Dolores Harper,
Donna Ltartaglino Besone,
Durell L Giles,
Dustin P Tran,
Edward E Lockwood (EEL),
Eileen T Dupont,
Elisa J Beard,
Eric C Fox,
Erin L Mcfiren,
Felix J Marrero,
Gary L Zaharek,
George T Allen, Jr,
Greg K Keshishyan,
Herminio C Francisco,
Iris C Macinnes,
J Elkins,
Jacqueline S Warner,
James A Barreto,
James D Hildreth,
James E Bentson,
James R Fleckenstein,
Janet Pulver,
Jeffrey J Thibodeau,
Jenny L Mccardell,
Jocelyn C Turner,
Jocelyn E Massey,
Joey V Quitania,
John A Gonzalez,
John E Emmert,
Joseph C Yen,
Juan A Morales,
Juanita Banuelos,
Juanj N Wu,
Judy C Nepsa,
Julian C Hanson,
Kaitlyn T Dang,
Katherine E Jacobitz,
Katlin N Stubbs,
Kelley,
Kelvin Cheung,
Kevin N Tran,
Kimberly Lewandowski Walker,
Kinh Q Mac,
Kirtida Patel,
Kristin M Abaonza,
Lance D Johnson,
LCDR Wilfred A Darang,
Leighton Kn Gai,
Leonard H Lavi,
Lilly O Barton,
Linda Galindo,
Linda Linh N Adams,
Linda Thai,
Lisa Shin,
Lucas B Leake,
Lydia S Chan,
Manuel A Moreno,
Marc R Dickens,
Marcus F Yambot,
Mark C Saale,
Matthew D Schnittker,
Michael D Garcia,
Minh D Phan,
Nicholas L Hunt,
Olalere D Fasipe,
Paul M Kawamoto,
Paul R Whitby,
Paul Z Balcer,
Pauline N Logan,
Philip M Steele, PhD,
Raymond W Brullo,
Rosanna M Goodrich,
Roy Baby,
Ruben G Abrajano,
Sandra L Shire, DMD, MPA,
Santiago Gallardo Johnson,
Scott A Nabe,
Scott D Stevens,
Scott K Zika,
Seema S Singh,
Selene T Torres,
Shafiq S Ahadi,
Sherri N Rohlf, MD,
Sonya L Karsik, RAC,
Stephen C Smith,
Stephen D Eich,
Stephen R Souza,
Steven R Ziser,
Stuart W Russell,
Sunitha K Rajaram, PhD,
Tamala P Magee,
Terri E Gibson,
That Q Dang,
Timothy C Grome,
Timothy T Kapsala,
Trudy R Papson,
Uttaniti Limchumroon (Tom),
Vickie L Anderson,
William H Shackelford,
William S Vitale,
Wr Bowman,
Yvette E Guillermo,
Zachary Ryan Harris
Marlo Ianm Alintanahin's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more